ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682825; 2) Community: the network communities that were significantly associated with the response to NSC 682825; 3) Molecule: the relationships between components within communities and NSC 682825; 4) MDR: the compounds that were significantly associated with the NSC 682825.

NSC Compound Enrichment Correlation
NSC 135037 Jatrophone 0.0385613993886001 0.69753671
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0385613993886001 0.24859576
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0385613993886001 0.37056338
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.0385613993886001 0.72248451
NSC 294961 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one 0.0385613993886001 0.60753093
NSC 303861 L-Cysteine analog 0.0385613993886001 0.61553742
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0385613993886001 0.63128108
NSC 339137 PHYSALOLACTONE 0.0385613993886001 0.34917331
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0385613993886001 0.17719439
NSC 371777 Null 0.0385613993886001 0.088333774
Total:161  Current:126    [First] [Prev] [Next] [Last]